In 1995, television reached Fiji for the first time. It’s one of the clearest diet culture origin stories on record. Before that, researchers found something striking: the culture had little concept of dieting, and eating disorders were nearly nonexistent. Thinness wasn’t a goal anyone was chasing, because it wasn’t really a category of thought at all.
Three years later, a follow-up study found that 74% of adolescent girls now considered themselves “too fat.” Disordered eating symptoms had risen sharply — in a population where, three years earlier, that framework barely existed. (The study’s sample was small, and some researchers have cautioned against over-generalizing from it — but the shift itself, however its exact scale is debated, is hard to explain away.)
The uncomfortable implication: the anxiety around body size may not be some universal human instinct waiting to surface. It may be something that gets imported — carried in by a specific aesthetic standard, from a specific media industry, landing on a culture that didn’t have it before.
Which raises an odd question for right now. GLP-1 drugs are going global, reshaping who gets access to weight-loss treatment and on what terms. As that happens, the category of “obesity” itself is quietly getting redefined — by new institutions, using new criteria, for reasons that have as much to do with markets as with health. It happened once through a television signal. It might be happening again, just as quietly, through a syringe.
My take
Thinness wasn’t an idea. Now it’s an Idea.